Results 41 to 50 of about 26,695,458 (198)
Comments/clarifications to the publication by Xin et al. (2025)
Xin et al. (2025) try to apply New Approach Methodologies (NAMs) for hazard identification and risk assessment using DINCH (cyclohexane-1,2-dicarboxylic acid, diisononyl ester, CAS Reg No 166412-78-8) as a model substance.
R. Otter +3 more
doaj +1 more source
An evaluation framework for new approach methodologies (NAMs) for human health safety assessment
The need to develop new tools and increase capacity to test pharmaceuticals and other chemicals for potential adverse impacts on human health and the environment is an active area of development. Much of this activity was sparked by two reports from the US National Research Council (NRC) of the National Academies of Sciences, Toxicity Testing in the ...
Stanley T. Parish +12 more
openaire +2 more sources
A framework for establishing scientific confidence in new approach methodologies
Robust and efficient processes are needed to establish scientific confidence in new approach methodologies (NAMs) if they are to be considered for regulatory applications.
BARROSO João +9 more
core +1 more source
Neurotoxicity of propylene glycol butyl ether: Multiomic evidence from human brainspheres
Exposure to solvents may contribute to the development of neurodevelopmental and neurodegenerative diseases. Glycol ethers consist in a widely used class of organic solvents leading to workers and consumers exposure via many applications. Ethylene glycol
David Lopez-Rodriguez +12 more
doaj +1 more source
Background/Objectives: Epilepsy remains a major neurological disorder, with approximately one-third of patients continuing to experience pharmacoresistant seizures despite the availability of numerous antiseizure medications (ASMs).
Wonseok Chang +5 more
doaj +1 more source
Advances in New Approach Methodologies at FDA's Division of Applied Regulatory Science. [PDF]
New Approach Methodologies (NAMs) represent a paradigm shift in drug development and regulatory science, offering human‐relevant alternatives to traditional preclinical models. This mini‐review highlights recent advances in NAM development, validation, and regulatory application from FDA's Division of Applied Regulatory Science (DARS).
Blinova K +9 more
europepmc +2 more sources
Despite some considerable advancement in developing different forms of new approach methodologies (NAMs) to assess the risk of chemicals, there is still limited progress in their application for regulatory purposes in the European Union (EU).
Aleksandra Čavoški +3 more
doaj +1 more source
New approach methodologies (NAMs): The strategic vision in science
Meeting report of the Sixth International Summer School of the Lake Como School of Advanced ...
Caloni, Francesca +9 more
openaire +2 more sources
This review comprehensively summarizes emerging biomaterial‐based strategies and underlying mechanisms for modulating endogenous tendon stem/progenitor cells (TSPCs). It offers the most recent insights into TSPC physiology and potential applications of tissue engineering and regenerative medicine in tendons.
Zeyu Zhu +9 more
wiley +1 more source
<p>Advanced material development, including at the nanoscale, comprises costly and complex challenges coupled to ensuring human and environmental safety.
Sørli, Jorid Birkelund +53 more
core +1 more source

